CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Pharmacokineticother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03454204
NCT03454204N/ACompleted

Pharmacokinetic and Pharmacodynamic Modelling of Norepinephrine in Patients Under Target Controlled Infusions (TCI) for Anaesthesia : Plasma Concentration and "Site Effect"

Assistance Publique - Hôpitaux de Paris·observational·Posted Mar 5, 2018·Updated Sep 14, 2023

In Brief

An observational study evaluating Pharmacokinetic for Neurosurgery and Intervention. Completed, enrolled 26 participants across 1 site.

Detailed Summary

Currently, administration of norepinephrine diluted at 5 µg/ml bolus or continuous infusion is common during sympatholysis hypotension of TCI following the elimination of hypovolemia or anesthetic overdosage. Continued intravenous administration must meet hemodynamic goals within a narrow time frame. Depending on the intensity of hypotension the dosage is variable. It is adjusted in real time while it is excessive or insufficient at times. Therefore, the development of modeling should predict the kinetic and hemodynamic effects based on dosage and individual.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 5, 2018
Enrollment StartJun 27, 2018
Primary CompletionJun 27, 2023
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 8.3 years ago

Interventions

Pharmacokineticother

Analysis of blood samples